Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danshen ethanol extract is a **lipid-soluble preparation** derived from the dried roots of *Salvia miltiorrhiza* Bunge (Danshen), a traditional Chinese medicinal herb. The extract is obtained through **alcohol-based extraction** and is rich in **lipophilic diterpene quinones**, particularly **tanshinones**, including tanshinone I, tanshinone IIA, and cryptotanshinone as the primary bioactive components. Unlike water extracts of Danshen that contain primarily phenolic acids, the ethanol extract contains **abietanoids and diterpene quinone pigments**. The extract has been traditionally used for treating cardiovascular and cerebrovascular diseases, including angina pectoris, myocardial infarction, and stroke. The ethanol extract demonstrates pharmacological activities including **induction of P-glycoprotein (MDR1)** and **CYP3A4**, leading to significant drug-drug interactions. Tanshinone IIA and cryptotanshinone in the extract have been shown to be **potent inhibitors of soluble epoxide hydrolase (sEH)**, with additional cardiovascular protective and anti-inflammatory effects. The extract exhibits **anti-oxidative**, **anti-inflammatory**, and **cardio-protective properties** through multiple mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Danshen ethanol extract.